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To assess long-term neurodevelopmental outcomes in school-aged children with biliary atresia (BA).  
Study design  
All Dutch children (6-12y), diagnosed with BA, were invited to participate in this study. We used 
validated neurodevelopmental tests to assess motor skills and cognition, and questionnaires to assess 
behavior. Scores were compared to age- and gender-matched Dutch norms, by means of one-sample 
tests. Results are given as number and percentages, or mean ± standard deviation.  
Results 
We included 46 children, with a median age of 11 years (6-13y). Thirty-six children had undergone a 
liver transplantation (LTx; 78%). Twelve children (26%) received special education (vs 2.4% in the 
norm population; p<0.01). Motor outcomes were significantly affected compared to the norm population 
(p<0.01), with 25% normal (vs 85%), 25% borderline (vs 10%) and 50% low scores (vs 5%). Total IQ 
was lower in BA patients, compared to the norm population (91±18 vs 100±15; p<0.01). There were no 
significant differences in test scores between children with native liver and post-LTx. 
 
Conclusions 
School-aged children with BA show neurodevelopmental impairments compared to the norm 
population, especially in motor skills. Our data strongly warrant evaluation of neurodevelopmental 






Biliary atresia (BA) is a rare liver disease of unknown etiology, manifesting in infants within the 
first weeks after birth. BA is characterized by obliteration and fibrosis of bile ducts, resulting in 
obstructive cholestasis. It is surgically treated by re-establishing the continuity between the portal bile 
ducts and the intestine via a Kasai porto-enterostomy (KPE). Despite a successful operation, however, 
liver cirrhosis is inevitable in most of the patients, making BA the leading indication for liver 
transplantation (LTx) in children.[1–3] BA is increasingly being considered a chronic disease with a 
necessity for more knowledge of long-term functional outcomes.  
Adequate neurodevelopment is essential for daily functioning and school performance. As early 
childhood is a time of critical brain growth, severe liver diseases as BA during this specific age-period 
could interfere with neurodevelopment.[4] In addition to the liver disease itself, other factors related to 
BA such as surgery, exposure to immunosuppressant treatments and repeated general anesthesia in early 
childhood are possibly related to impaired neurodevelopment.[5–7] Moreover, growth deficits and 
impaired nutritional status may influence the developing brain.[4,8] This could result in impaired 
neurodevelopmental outcomes in several areas of neurodevelopment, such as cognition, behavior and 
motor outcome.[4] As recently highlighted, studies on the neurodevelopment of children with chronic 
disease are needed to understand the nature of these impairments.[9] Still little is known about the 
neurodevelopmental sequelae of BA and possible risk factors for impaired neurodevelopmental 
outcomes. Recently, results from the Childhood Liver Disease Research Network showed that infants 
with BA, surviving with native liver, had impaired neurodevelopmental outcomes at 12 and 24 months 
of age.[10] However, studies on long-term neurodevelopmental outcomes, exclusively including 
children with BA, are scarce. Especially data on school performance and motor skills are lacking. 
Therefore, the first aim of this study was to assess long-term neurodevelopmental outcomes in Dutch 
children with BA at school age; to determine which areas of neurodevelopment are affected and to what 
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degree. The second aim was to identify risk factors associated with impaired neurodevelopmental 
outcomes.   
 
Patients and Methods  
In the Netherlands, the care for all infants with (congenital) liver disease is centralized in our 
center nowadays. Children were selected using the Dutch nationwide database known as Netherlands 
Study group of Biliary Atresia, the NeSBAR. All parents/guardians of school-aged children aged 6 to 12 
years at time of invitation, who have been diagnosed with BA, were asked to participate in this study. 
We choose to include all eligible children with BA, including children with BA who were born 
prematurely and children with a history of intracranial hemorrhage, to provide a complete overview of 
this patient group. The inclusion period spanned from 2015 to 2018. All children had undergone a KPE 
between 2002 and 2012, in one of the seven Dutch academic pediatric surgical centers that performed 
this type of surgery at that time. Exclusion criteria for this study were insufficient command of the 
Dutch language or no child assent. This study was carried out in accordance with the Declaration of 
Helsinki and approved by the ethics committee (METc UMCG 2011/185). 
 
Data collection 
After obtaining written informed consent of both parents/guardians, and of children of 12 years 
of age, children were scheduled for a neurodevelopmental assessment. A history was taken for each 
child, including whether the child had study delay or attended special education and whether the child 
had received neurodevelopmental intervention (physiotherapy, speech language therapy, psychology). 
For each child, the following parameters were reported: birth weight, history of intracranial hemorrhage, 
Biliary Atresia Splenic Malformation syndrome yes/no, age at KPE, clearance (serum bilirubin 
concentration <20 µmol/L within 6 months after KPE) yes/no, highest bilirubin level pre-KPE and 
during screening LTx, LTx yes/no, age at LTx, major complication after LTx, minimum total times of 
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general anesthetics, already diagnosed psychomotor retardation yes/no, level of education, history of 
neurodevelopmental intervention, as well as history of growth failure (SD<2) and growth and weight Z-
scores at time of test assessment. In addition, demographic information on parents was reported, such as 
ethnicity and level of education. 
 
Neurodevelopmental outcome measures  
We used a carefully selected a validated test battery for the patient, and parental questionnaires, 
to assess neurodevelopmental outcomes. The selected tests and questionnaires are widely used in 
neuropsychology, both in the Netherlands, as well as worldwide.[4] Multidimensional data on motor 
skills, cognition, behavior, and social-emotional development, were assessed by two trained test-
assistants. The Movement Assessment Battery for Children (M-ABC) was applied to assess motor 
skills.[11] To assess cognitive outcomes, we used subtests of the Wechsler Intelligence Scale for 
Children, 3rd edition in Dutch, as the 4th edition was not available in Dutch (WISC-III-NL; total 
intelligence quotient (IQ), verbal IQ and performance IQ).[12] In addition, we used the Test of 
Everyday Attention for Children (TEA-Ch; selective attention and inhibition control),[13] Auditory 
Verbal Learning Test (AVLT; auditory memory),[14] Beery-Buktenice Developmental Test of Visual-
Motor Integration, 6th edition, (Beery-VMI-6; visuomotor integration),[15] Test of Visual Perceptual 
Skills, 3rd  edition (TVPS; visual-perceptual abilities),[16] and for children > 8 years of age also the 
Behavioural Assessment of the Dysexecutive Syndrome for Children (BADS-C; executive functioning; 
planning and strategy formation).[17] The psychometric qualities of all tests are satisfactory.[18–24] 
Moreover, to obtain additional information about behavior and executive functioning of the children, the 
following parental questionnaires were used: the ADHD questionnaire (ADHD-vragenlijst, AVL, in 
Dutch),[25] the Child Behavior Checklist (CBCL) for Children aged 6-18 (internalizing and 
externalizing problems),[26] and the Behavior Rating Inventory of Executive Function (BRIEF) 
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questionnaire (executive functions).[27] Children with a known psychomotor retardation, who were not 
able to perform neurodevelopmental tests, were included in categorical variables as ‘low’ score.   
 
Data analysis 
Data on the measured parameters were investigated for their distribution using standard 
descriptive analyses. When data was not normally distributed, the parameter was described by either 
medians and its corresponding range of min to max, or percentiles for categorical data. Raw scores were 
transformed to age and gender corrected percentiles or Z-scores based on norm data, as supplied by the 
test manuals.[11–17,25–27] To provide one outcome for the two TVPS subtests, the mean Z-score was 
calculated. In addition, scores were classified as normal (IQ>85; percentile >15), borderline (IQ 70-85; 
percentile 6-16) or low (IQ<70; percentile <6), based on the Dutch norm population, in accordance with 
the test manual.(9-18) IQ scores and Z-scores were compared to the norm population (IQ 100 ± 15; Z-
score 0 ± 1) by means of either the one-sample T-test for normally distributed data, or the one-sample 
Kolmogorov Smirnov test for non-normally distributed data. The categorized outcomes were compared 
to the norm population using the chi-square or the Fisher exact test.  
To investigate the relation between total IQ or motor score percentile and risk factors, either the 
independent sample T-test for dichotomous variables or correlation analysis for continuous variables 
was performed in addition to univariate regression analyses. Risk factors with a p-value <0.20 were 
included in a multivariate backward stepwise regression analysis. Linear regression analysis was used 
for total IQ. As data on motor skills did not fulfil assumptions for linear regression, a logistic regression 
model was built for normal/borderline vs low motor scores. Results were checked after multiple 
imputations (overall missing data 3%). Effect sizes were calculated by describing the mean difference in 
SD of children with BA with that of the general populations [(meanBA-meannorm)/SD].[28] Effect sizes 
and study power were calculated using the G*Power program, version 3. An observed p<0.05 was 




Within a timeframe of 4 years (2015-2018), 59 school-aged children with BA in the Netherlands 
were contacted for inclusion after identification through the NeSBAR database (Figure 1; online). Of 59 
contacted children, 46 (78%) were included. Reasons for exclusion were: insufficient mastery of Dutch 
language (n=1), emigration (n=1), currently being tested due to a possible transfer to special education 
(n=1), no show (n=1), or no informed consent (n=9). Of the 46 included children, 3 were not able to 
perform the neurodevelopmental tests due to already diagnosed psychomotor retardation. One of these 
children suffered from meningitis in the first months after birth, however, the cause of the psychomotor 
retardation remained uncertain. Patient characteristics are listed in Table 1. Five children were born 
preterm (11%), of whom one child was born <35 weeks post-menstrual age. Eight children (17%) 
presented with an intracerebral hemorrhage secondary to vitamin K deficiency, prior to the diagnosis of 
BA.[29,30] At time of test-assessment 21 children (46%) had received neurodevelopmental 
interventions at some point in life, in the form of physiotherapy (n=8, 17%), speech language therapy 
(n=10, 22%), psychology (n=7, 15%), or other (n=3, 7%). Up to 40% of these children received 
interventions for a duration >1 year, of whom 25% received intervention for >2 years. Household 
education was somewhat higher in the study population than in the Dutch norm population, although not 
statistically significant (63% high education vs 45% in the norm population of Dutch working citizens 
aged 25-45; p<0.33).[31]   
 
School performance 
Of the 46 children, 27 (59%) received formal education, seven (15%) received formal education 
with additional support and twelve children received special education (26% vs 2.4% in the Dutch norm 
population, p=<0.01).[32] Of the 34 children receiving formal education, 8 (24%) children had a study 





Motor outcome was significantly lower (p<0.001) compared to the norm population with 25% 
normal (vs 85%), 25% borderline (vs 10%) and 50% low scores (vs 5%). All tested motor domains were 
significantly affected, e.g. fine skills, ball skills and balance. Figure 2 shows the motor outcomes 
expressed in normal, borderline and low scores. Table 5 (online) provides effect sizes and study power. 
 
Cognitive outcomes 
The mean total IQ of children with BA was 91±18, and significantly lower (p=0.002) than in the 
Dutch norm population (mean IQ 100±15). The mean performance IQ was 88±18 (p<0.001), and the 
mean verbal IQ was 96±17 (p=0.09). When divided into normal, borderline and low scores, children 
scored significantly lower when compared to the norm population (Figure 2).  
In other cognitive domains, children with BA scored significantly lower on both subtests of 
attention (selective attention, Z-score -0.64; p=0.001, and inhibition control, Z-score -0.41; p=0.01), 
visuomotor integration (Z-score -0.59; p<0.001), perceptual ability (Z-score -0.40; p=0.01), and 
planning (Z-score -0.42; p=0.002). There were no significant differences in verbal short- and long-term 
memory, or strategy formation. Age- and gender-matched Z-scores, based on the Dutch norm 
population, are displayed in Figure 3. 
 
Behavioral outcomes 
The parent-reported questionnaires showed significantly more behavioral problems in BA 
children, compared to the norm population (Table 2). Parents of children with BA reported a 
significantly higher prevalence of overall behavioral difficulties (23% vs norm 2%; p<0.001), attentional 
problems (10% vs norm 5%; p=0.005) and hyperactivity (18% vs norm 5%; p=0.003). There were no 




Risk factors  
Data on the regression analyses of motor skills are shown in Table 3 (online). Univariate analysis 
revealed a significant effect of male gender (OR 4.91, 95% CI 1.33, 18.21; p=0.017) on low motor 
skills. The final model after multivariate analysis showed low odds for impaired motor skills in children 
with an history of intracranial hemorrhage, although not statistically significant (OR 0.20, 95% CI 0.03, 
1.30; p=0.09), and high odds for male gender (OR 5.74, 95% CI 1.45, 22.81; p=0.013).  
The regression model of total IQ is shown in Table 4 (online). Univariate analysis showed a 
significant effect of selective attention abilities (mean difference (β) 0.25, 95% CI 0.06, 0.45; p=0.012) 
and history of neurodevelopmental intervention (β -15.60, 95% CI -25.50, -5.70; p=0.003) on total IQ. 
Both variables remained significant after multivariate regression analysis. Results did not differ after 
multiple imputations of missing data (data not shown). 
Overall, there were no significant differences between children with native liver and children 
after LTx. Children with native liver had a mean total IQ of 94±10 vs a mean total IQ of 90±19 after 
LTx (p=0.533). All 8 children with ‘low’ IQ score had undergone a LTx. In motor outcomes, 4/10 
(40%) children with native liver scored ‘low’ vs 18/34 (53%) children after LTx (p=0.46). Concerning 
school performance, 4/10 (40%) children with native liver received special education vs 8/36 (22%) 
children after LTx (p=0.29). Gestational age was not significantly associated with lower IQ or abnormal 
motor skills.  
 
Discussion 
The first aim of this study was to assess neurodevelopmental outcomes in Dutch children with 
BA at school age, to determine which areas of neurodevelopment are affected and to what degree. We 
found significantly impaired neurodevelopmental outcomes compared to the norm population. These 
impairments were present in all neurodevelopmental domains, i.e. motor skills, cognition, and behavior. 
Motor outcomes were most affected, with even up to half of the children scoring ‘low’ on motor skills. 
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In addition, children scored significantly lower on total IQ, performance IQ, attention abilities, planning, 
visuomotor integration and perceptual ability as compared to the norm population. Moreover, parents 
reported behavioral and attentional problems in children with BA. Remarkably, one in four children 
with BA received special education, a significantly higher percentage than the 2.4% in the general 
Dutch population.  
The second aim was to identify risk factors for impaired neurodevelopmental outcomes. Of the 
46 children with BA, 36 (78%) had a history of LTx. Children surviving with native liver did not score 
significantly higher on several subtests of cognition and motor skills compared to children after LTx. 
However, there was a trend for higher scores on these subtests in native liver survivors, but this did not 
reach statistical significance. We therefore refrained from scrutinizing the differences in specific 
neurodevelopmental subdomains between children with native liver and those that underwent LTx. A 
note of caution is however due while interpreting these data, considering the small proportion of 
children surviving with native liver. Nevertheless, our findings are in line with previous literature 
describing impaired neurodevelopmental outcomes in children with native liver and after 
LTx.[10,33,34] These findings raise intriguing questions regarding the underlying pathophysiology of 
neurodevelopmental impairments in children with congenital liver disease. One could speculate that the 
neurodevelopmental delays were caused by exposure of the developing brain to cholestasis rather than, 
or in addition to, LTx. Wayman et al. showed that the neurodevelopmental outcomes of children with 
BA were in the low-average range before LTx. After LTx scores declined significantly in the first 
months, however, returned to the same level as pre-LTx scores 1 year after LTx, not exceeding pre-LTx 
scores.[35] Previous research showed a correlation between cholestasis and impaired cognitive 
outcomes.[36,37] Cholestasis might cause brain lesions, especially in the white matter, which is 
believed to be the neural foundation for general intelligence.[38] Recently, Talcott et al. showed 
alterations in the brain biochemistry of children with liver disease, including children with 
asymptomatic liver disease.[37] All children with BA are faced with cholestasis prior to KPE surgery, 
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and many also after KPE, making this a possible cause for neurodevelopmental impairments. Major 
surgery in young children itself may also be a possible risk factor for impaired neurodevelopment. 
Physiological stress and anesthesia can be harmful in the period of early brain development.[5,39] On 
the other hand, Davidson et al. stated that general anesthesia in infants has no significant effect on 
neurodevelopmental outcomes at 2 years of age, although in relatively minor surgery.[6]  
 In line with previous studies, boys had higher odds of neurodevelopmental impairments, 
especially motor skills.[40–42] Both sex hormones and sex chromosome genes may influence brain 
function, for example, the Y-chromosome gene is suggested to be a male-specific risk factor for 
neurodevelopmental disorders.[41] Surprisingly, prematurity was not a risk factor for 
neurodevelopmental impairments at school age in our cohort. Moreover, our data showed no difference 
in IQ, and even better motor skills, in children with a history of intracranial hemorrhage, compared to 
children without a history of intracranial hemorrhage.  
  Exact pathophysiology and age at onset of the neurodevelopmental impairments remain unclear. 
Data on neurodevelopmental outcomes at earlier age are scarce, though required to further investigate 
age at onset and underlying pathophysiology of these impairments. Moreover, longitudinal follow-up is 
essential to explore the long-term neurodevelopmental trajectory in children with BA. 
At time of test assessment, 46% of children had already received some type of 
neuropsychological intervention. However, this was not integrated in standard care. Children with a 
history of neuropsychological intervention had significantly lower scores on motor skills and IQ. The 
effectiveness of these neuropsychological interventions remains uncertain; however, we can conclude 
that they were not sufficient to fully recover the impairments. Previous studies have shown that, in 
preterm infants, early intervention programs have a positive effect on motor development in infancy, 
and cognitive development up to preschool age, compared to standard medical follow-up.[43] Early 
identification of infants with BA at risk for neurodevelopmental impairments may allow the start 
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targeting intervention programs at early age, focusing on infant development and parent-infant 
relationship, e.g. in the form of physiotherapy, speech language therapy and psychological intervention.  
A chronic disease, as BA, might also influence health- related quality of life. Existing data on quality of 
life in children with BA is contradictory, with some studies describing lower health-related quality of 
life, whereas others describe similar quality of life.[44,45] Further research is needed to investigate 
whether impaired neurodevelopmental outcomes negatively affect the health-related quality of life in 
children with BA. 
  We are aware that our study has some limitations. As BA is a rare disease, the sample size was 
relatively small, especially regarding children surviving with native liver. The sample size might have 
masked differences between subgroups of children, e.g. children with native liver and after LTx, or 
some previously recognized associations between risk factors and neurodevelopmental outcomes. 
Furthermore, most of the children displayed problems with hyperactivity and attention. Univariate 
analysis showed that selective attention abilities were associated with IQ scores, however, not with 
motor skills. Moreover, the cross-sectional study design limits exploration of neurodevelopmental 
outcomes over time. In addition, we did not receive informed consent from 11 of the invited children. It 
is unknown whether these children reflect either the highest or lowest scoring children. Nevertheless, the 
inclusion ratio was high (78%) and, therefore, we feel that our cohort provides an adequate overview of 
children with BA from the Netherlands.  
  In conclusion, this study shows impaired outcomes in several very important fields of 
neurodevelopment in school-aged children with BA, e.g. motor skills, cognition and behavior. 
Moreover, 27% of children received special education. Our data strongly warrant evaluation of 
neurodevelopmental intervention programs to assess whether long-term outcomes could be improved. 
International collaboration and pooling of data is highly desirable to further investigate the underlying 
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Figure 1. Flow chart of the inclusion process. 
 
Figure 2. Distribution of motor scores (n=44) and IQ (n=46) in children with biliary atresia compared to 
reference values based on the Dutch norm population (age- and gender-matched).  
Significance: * = p < 0.001 using the Fisher exact test.  
 
Figure 3. Boxplot of (age- and gender-matched) Z-scores of neurodevelopmental outcomes in children 
with biliary atresia compared to the Dutch norm population (Z-score 0, SD 1).  
Significance: * = p < 0.05 using the one-sample Kolmogorov Smirnov test.  
IM-ABC (n=42), IIWISC-III-NL (n=43), IIITEA-Ch (n=42), IVAVLT (n=41), VBEERY-VMI-VI (n=42), 
















Table 1. Patient characteristics 
 
 
Patient characteristics  N=46 N (%), mean ±SD,  
median (range) 
Male gender 46 27  (59%) 
Gestational age (weeks) 43 39  (30 – 42) 
Caucasian  45 35  (78%) 
Highest household education 38  
- High  24  (63%) 
- Intermediate   10  (26%) 
- Low  4  (11%) 
Follow-up   
- Age at follow-up (years) 46 11  (6 – 13) 
- Median height (SD) 40 0.19  (-3.5 – 1.9)  
- Median weight for height (SD) 36 0.58  (-1.7 – 2.6) 
Education child  46  
- Formal education  27  (59%) 
- Formal education with additional support  7  (15%) 
- Special education  12  (26%)  
History of neurodevelopmental intervention 46 21  (46%) 
Medical history   
Intracranial hemorrhage 46 8  (17%)  
BASM 46  2  (4%) 
Diagnosed psychomotor retardation  46 3  (7%) 
History of growth failure (SD<2) 42 20  (48%) 
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KPE  45  (98%) 
Age at KPE (days) 45 60 ±18  
KPE <60 days of life 46 24  (52%) 
Total bilirubin serum level pre-KPEa 44 179 (78 – 339) 
Direct bilirubin serum level pre-KPEb 42 135  (41 – 308) 
Successful KPEc 45 12  (27%) 
LTx  36  (78%) 
Age at LTx (months) 35 11  (4 – 149) 
Time since LTx (years)  35 9  (1 – 12) 
Living related LTx 33 12  (36%) 
Hospitalization after LTx (days) 32 33  (12 – 159)  
Major complicationd  33 23  (70%) 
Total bilirubin level screening LTxa  35 161  (12 – 584) 
Direct bilirubin level screening LTxb 34 133  (4 – 427)  
Data are given as numbers (percentage), mean ± SD, or as median (minimum-
maximum). Normal values: a<17 µmol/L, b<5 µmol/L, cbilirubin level <20µmol/L (1.17 










Table 2. Behavioral outcomes in children with BA  
 N Normal Borderline Low p 
CBCL   ref 93% 5% 2%  
Internalizing problems 39 18 (46%) 6 (15%) 15 (39%) <0.001 
Externalizing problems 38 28 (74%) 3 (8%) 7 (18%) <0.001 
Total behavioral problems 34 20 (59%) 6 (18%) 8 (23%) <0.001 
AVL   ref 90% 5% 5%  
Attentional problems  40 31 (78%) 5 (12%) 4 (10%)  0.03 
Hyperactivity  39 29 (74%) 3 (8%) 7 (18%) 0.003 
Impulsivity  39 35 (90%) 3 (8%) 1 (2%) 0.67 
Total ADHD  38 29 (76%) 8 (21%) 1 (3%) 0.001 
BRIEF   ref 50% 43% 7%  
Behavioral regulation 39 20 (51%) 16 (41%) 3 (8%) 0.97 
Metacognition 37 20 (54%) 13 (35%) 4 (11%) 0.46 
Global executive composite  37 19 (51%) 14 (38%) 4 (11%) 0.65 
Distribution of behavioral outcomes of children with BA, in normal, borderline and 
low scores, compared to the norm population using the Fisher exact test. Scores are 









Table 3. The association between motor skills and risk factors 
 Motor skills 
(percentile) 
Low score motor skills  
(percentile < 5) 
  Descriptives Univariate Multivariate 
 N=43 Median (range) 
or rho 
 OR  [95% CI] OR    [95% CI] 
Gender     
-  Girls 19 11  (2-92) ref ref 
-  Boys 27 3  (1-25) * 4.91  [1.33, 18.21]*  5.74  [1.45, 22.81]* 
Ethnicity      
-  Caucasian 32 6.5  (1-92) ref  
1.80  [0.43, 7.59] 
 
-  Non-Caucasian 9 4  (1-67) 
Highest household education     
- Low/intermediate  18 6.5  (1-92) ref  
- High  23 6  (1-75) 1.00  [0.31, 3.28]  
Gestational age (weeks) 38 -0.05 1.05  [0.82, 1.35]  
Intracranial hemorrhage     
ref 
0.20  [0.03, 1.30]† 
- no 34 5  (1-92)  ref 
- yes 7 19  (1-67)† 0.27 [0.05, 1.50]† 
History of growth failure (SD<2)     
- no  20 7.5 (1-92) ref 
- yes 18 8.5  (1-75) 1.50  [0.43-5.25] 
History of neurodevelopmental intervention      
- no  22 9 (1-92) ref  
- yes 19 2  (1-67)* 2.10  [0.63-7.03]  
Successful KPEa     
- no  28 6.5  (1-92) ref 











- yes 12 9  (1-75) 0.67  [0.17-2.57] 
KPE <60 days of life     
- no  19 10  (1-92)  ref 
- yes 22 5  (1-67) 1.73  [0.53-5.72] 
Age at KPE (days) 40 0.12 0.97  [0.94-1.01]† - 
Total bilirubin serum level pre-KPEb 41 -0.09 0.99  [0.99-1.01]  
Direct bilirubin serum level pre-KPEc 32 0.12 1.00  [0.99-1.01]  
LTx     
- no  10 6  (1-75)  ref  
- yes 31 7  (1-92) 1.69  [0.40-7.07]  
Selective attention (percentile) 42 0.19 0.99  [0.97-1.02]  
Significance: * = p-value <0.05, † = p-value <0.2.  CI = confidence interval, OR = odds ratio 
Dichotomous risk factors and motor score percentiles were compared by using the Mann Whitney U test. The correlations between motor 
score percentiles and continuous risk factors were calculated by means of Spearman’s rho. Odds ratio’s (ORs) were calculated using 
logistic regression. Variables with p-value <0.2 were included in multivariate analysis, and the final model after backward regression is 
shown.   
Normal values: abilirubin level <20µmol/L (1.17 g/dL) within 6 months post-KPE, b<17 µmol/L, c<5 µmol/L.  
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Table 4. The association between total IQ and risk factors 
 Total IQ (absolute number) 
 Descriptives Univariate Multivariate 
 N=43 Mean ± SD  
or rho 
β  [95% CI] β  [95% CI] 
Gender     
-  Girls 19 96 ± 12 ref  
-  Boys 24 88 ± 21† -8.04  [-18.85, 2.77]† - 
Ethnicity      
-  Caucasian 34 94 ± 15 ref  
-  Non-Caucasian 9 82 ± 24† -11.92  [-24.95, 1.10]†   - 
Highest household education     
- Low/intermediate  
- High 
20 87 ± 15 
95 ± 19† 
ref  
8.12  [-2.64, 18.88]† 
 
23 - 
Gestational age  40 0.02 -0.11  [-2.52, 2.30]   
Intracranial hemorrhage    
ref 
2.12  [-12.82, 17.03]  
 
- no 36 91 ± 19  
- yes 7 93 ± 9  
History of growth failure (SD<2)    
ref 
 -6.01  [-16.62, 4.60] 
 
- no  
- yes  
22 
18 
92 ± 17 
86 ± 16 
 
History of neurodevelopmental 
intervention  




- no  23 98 ± 13 ref 
- yes 20 83 ± 19† -15.60  [-25.50, -5.70]* -15.84  [-25.14, -6.55]* 
Successful KPEa    
ref 
 
- no  30 91 ± 19  











- yes 12 93 ± 12 1.72  [-10.27, 13.71]   
KPE <60 days of life    
ref 
10.55  [0.01, 21.09]† 
 
- no  20 85 ± 20 
96 ± 14† 
 
- yes 23 - 
Age at KPE (days) 42 -0.12 -0.09  [-0.38, 0.21]  
Total bilirubin serum level pre-KPEb 43 -0.17 -0.06  [-0.15, 0.04]  
Direct bilirubin serum level pre-KPEc 34 -0.10 -0.06  [-0.16, 0.04]  
LTx     
- no  10 94 ± 10 ref  
- yes 33 90 ± 19 -4.05  [-17.04, 8.94]  
Selective attention (percentile) 42 0.39 0.25  [0.06, 0.45]* 0.24  [0.07, 0.41]* 
Significance: * = p-value <0.05, † = p-value <0.2. β = difference in mean, CI = confidence interval. 
Dichotomous risk factors and IQ were compared using the independent sample T test. The correlations between IQs and 
continuous risk factors were calculated by means of Spearman’s rho. Variables with p-value <0.2 were included in 
multivariate analysis, and the final model after backward regression is shown.  




Table 5. Effect sizes and study power  
Outcomes Effect size Study power 
 Cohen’s d  
Total motor skills 1.38 1.00 
Total IQ 0.49 0.94 
Performance IQ 0.72 1.00 
Verbal IQ 0.37 0.77 
Selective attention 0.64 0.99 
Inhibition control 0.41 0.83 
Short-term memory 0.02 0.06 
Long-term memory 0.20 0.34 
Visuomotor integration 0.59 0.98 
Perceptual ability 0.40 0.81 
Planning 0.42 0.64 
Strategy formation 0.19 0.23 
Multivariate model - IQ f2  
Total model 0.45 0.97 
Multivariate model - motor skills f2  
Total model  0.45 0.92 
Cohen’s effect sizes are interpreted as small (d=0.20 or f2=0.02), medium 
(d=0.50 or f2=0.15), and large (d=0.80 or f2=0.35). Effect sizes and study 
power were calculated using the G*Power program, version 3.  
 
 
 
